Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

DERMATITIS

N/A

10.1097/DER.0000000000000814

WOS:000797604000003

http://hdl.handle.net/11368/3027625

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85130864266

https://journals.lww.com/dermatitis/Citation/2022/05000/Patients_Withdrawing_Dupilumab_Monotherapy_for.13.aspx

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154081/

open access

license:copyright editore

license:digital rights management non definito

license uri:iris.pri02

license uri:iris.pri00

https://arts.units.it/request-item?handle=11368/3027625